241 / 320
645
21. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective
randomised multi-centre controlled trial on tight glucose
control by intensive insulin therapy in adult intensive care units:
the Glucontrol study. Intensive Care Med. 2009;35(10):1738-
48.
22. Finfer S, Chittock D, Li Y, et al. Intensive versus Conventional
Glucose Control in Critically Ill Patients. The NICE-SUGAR Study
Investigators. N Engl J Med 2009; 360:1283-1297.
23. Kohn L. The Institute of Medicine report on medical error:
Overview and implications for pharmacy. Am J Health Syst
Pharm 2001;58: 63-6.
24. Leape L, Bates D, Cullen D, et al. Systems Analysis of Adverse
Drug Events. JAMA 1995;274: 35-43.
25. Seynaeve S, Verbrugghe W, Claes B, Vandenplas D, Reyntiens D,
Jorens PG. Adverse drug events in intensive care units: a cross-
sectional study of prevalence and risk factors. Am J Crit Care.
2011;20(6):131-40.
[CONSIDERACIONES FARMACOLÓGICAS GENERALES Y PARTICULARES EN CUIDADOS INTENSIVOS - Dr. Tomás Regueira, PhD]